Henry Jemil Esber's Net Worth

-$781 Thousand

Estimate Recalculated Nov 1, 2024 05:26AM EST

Who is Henry Jemil Esber?

Henry Jemil Esber does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include INNOVUS PHARMACEUTICALS, INC., Boston Therapeutics, Inc., PRO PHARMACEUTICALS INC, and NEXMED INC.

SEC CIK

Henry Jemil Esber's CIK is 0001391501

Past Insider Trading and Trends

2014 was Henry Jemil Esber's most active year for acquiring shares with 9 total transactions. Henry Jemil Esber's most active month to acquire stocks was the month of December. 2015 was Henry Jemil Esber's most active year for disposing of shares, totalling 1 transactions. Henry Jemil Esber's most active month to dispose stocks was the month of November. 2010 saw Henry Jemil Esber paying a total of $870,657.31 for 2,093,283 shares, this is the most they've acquired in one year. In 2015 Henry Jemil Esber cashed out on 2,949,145 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

INNOVUS PHARMACEUTICALS, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Apr 1
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Oct 1
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Apr 1
Form 4
—
0
—
—
0
Feb 23
Form 4
∞
100K
$0.09
$9,292.00
100K
Nov 23
Form 4
—
0
—
—
0
Oct 1
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Apr 1
Form 4
—
0
—
—
0
Jan 1
Form 4
—
0
—
—
0
Oct 1 - Nov 16
Form 4
—
0
—
—
0
Apr 1
Form 4
—
0
—
—
0
Jan 29
Form 4
—
0
—
—
0
Jan 4
Form 4
-100.00%
-2.95M
—
—
0
Dec 30
Form 4
—
0
—
—
0
Oct 1
Form 4
—
0
—
—
0
Jul 2
Form 4
—
0
—
—
0
Apr 1
Form 4
—
0
—
—
0
Mar 31
Form 4
+2.10%
37.5K
—
—
1.83M
Jan 2
Form 4
+0.91%
16.22K
—
—
1.79M
Oct 1
Form 4
+1.27%
22.22K
—
—
1.77M
Jul 1
Form 4
+0.84%
14.63K
—
—
1.75M
Apr 1
Form 4
+15.14%
228.27K
—
—
1.74M
Feb 19
Form 4
+1.01%
15K
—
—
1.51M
Feb 4
Form 4
+0.25%
3.75K
—
—
1.49M
Oct 16
Form 3
—
0
—
—
0
No matching records found

Boston Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+225.00%
9K
$0.20
$1,800.00
13K
Sep 25 - Mar 18
Form 4
—
0
—
—
0
Nov 8 - Mar 13
Form 3
—
0
—
—
0
No matching records found

PRO PHARMACEUTICALS INC (GALT) Snapshot price: $2.39

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 8
Form 4
—
0
—
—
0
Mar 13
Form 4
—
0
—
—
0
Mar 8
Form 3
—
0
—
—
0
No matching records found

NEXMED INC (SEEL) Snapshot price: $0.2305

EVP Pre-Clinical Business Dev.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.41%
2.5K
$5.13
$12,850.65
609.22K
Jan 3
Form 4
+11.55%
62.84K
$3.58
$8,967.90
606.71K
Jun 14 - Sep 30
Form 4
+0.46%
2.5K
$3.55
$8,890.24
543.88K
Jul 1
Form 4
+11.59%
159.5K
$3.55
$8,890.24
1.54M
Dec 14 - May 16
Form 4
+160.26%
353.63K
$2.52
$891,135.00
574.28K
Jun 21
Form 4
+4.71%
100K
—
—
2.22M
Apr 9
Form 4
+211.88%
2.18M
$0.17
$366,350.38
3.21M
Mar 15
Form 4
+52.69%
355.14K
$0.17
$59,663.35
1.03M
Jan 11
Form 3
—
0
—
—
0
No matching records found